July 6, 2021 Experience Zylox-Tonbridge Medical Technology HK$2.56 billion IPO We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
June 30, 2021 Experience Nayuki Holdings HK$5.1 billion IPO We advised Nayuki Holdings on its IPO and HKEX listing
June 22, 2021 Experience Youran Dairy HK$5 billion IPO We advised Youran Dairy on its IPO and HKEX listing
June 21, 2021 Experience CARsgen Therapeutics HK$3.1 billion IPO We advised CARsgen Therapeutics on its IPO and HKEX listing
March 31, 2021 Experience Bairong HK$3.76 billion IPO We advised the underwriters on the IPO and HKEX listing
March 24, 2021 Experience Baidu HK$23.9 billion IPO and secondary listing on the Hong Kong Stock Exchange In addition to the HKEX listing, Baidu’s ADSs trade on the Nasdaq Global Select Market
February 26, 2021 Experience JOINN Laboratories HK$6.5 billion IPO We advised JOINN Laboratories on its IPO and HKEX listing.
February 18, 2021 Experience New Horizon Health HK$2.04 billion IPO We advised New Horizon Health on its IPO and HKEX listing
December 10, 2020 Experience Pop Mart HK$5.2 billion IPO and Hong Kong listing Davis Polk advised Pop Mart International Group Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance…